Metastasin leads to poor prognosis of hepatocellular carcinoma through partly inducing EMT

Oncology Reports

Volumn 29, Issue 5, 2013, Pages 1805-1810

  Zheng, Xin ^a   Gai, Xiaohong ^a   Wu, Zhenhua ^b   Liu, Qingguang ^a   Yao, Yingmin ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b XinJiang Tumor Hospital   (China)

Author keywords

Epithelial mesenchymal transition; Hepatocellular carcinoma; Metastasin; Prognosis

Indexed keywords

BETA GALACTOSIDASE; BMI1 PROTEIN; CLUSTERIN; COPPER SULFATE; MESSENGER RNA; PROTEIN P16; PROTEIN P21; SOMATOMEDIN BINDING PROTEIN 3; TRANSFORMING GROWTH FACTOR BETA1; CADHERIN; CDH2 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PROTEIN S 100; S100A4 PROTEIN, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR; VIMENTIN;

APOJ GENE; ARTICLE; BMI1 GENE; CANCER CELL CULTURE; CELL AGING; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME ACTIVITY; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IGFBP3 GENE; INTRACELLULAR SIGNALING; P16 GENE; P21 GENE; PRIORITY JOURNAL; TGF BETA1 GENE; WESTERN BLOTTING; ADULT; AGED; BIOSYNTHESIS; CELL MOTION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENETICS; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE; TUMOR INVASION; UPREGULATION;

ADULT; AGED; ANTIGENS, CD; CADHERINS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; S100 PROTEINS; TRANSCRIPTION FACTORS; UP-REGULATION; VIMENTIN;

EID: 84895699166     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2341     Document Type: Article

References (36)

1. Yang JD and Roberts LR: Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol 7: 448-458, 2010.
2. Ma W, Wong CC, Tung EK, Wong CM and Ng IO: RhoE is frequently downregulated in HCC and suppresses HCC invasion through antagonizing the Rho/ROCK/MYPT pathway. Hepatology 57: 152-161, 2012.
3. Berge G and Maelandsmo GM: Evaluation of potential interactions between the metastasis-associated protein S100A4 and the tumor suppressor protein p53. Amino Acids 41: 863-873, 2011.
4. Mishra SK, Siddique HR and Saleem M: S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence. Cancer Metastasis Rev 31: 163-172, 2012.
5. Ambartsumian N, Klingelhofer J, Grigorian M, et al: The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor. Oncogene 20: 4685-4695, 2001. (Pubitemid 32762440)
6. Saleem M, Kweon MH, Johnson JJ, et al: S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc Natl Acad Sci USA 103: 14825-14830, 2006. (Pubitemid 44527813)
7. Stein U, Arlt F, Walther W, et al: The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer. Gastroenterology 131: 1486-1500, 2006. (Pubitemid 44708942)
8. Takenaga K, Nakanishi H, Wada K, et al: Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas. Clin Cancer Res 3: 2309-2316, 1997. (Pubitemid 28133150)
9. Ilg EC, Schafer BW and Heizmann CW: Expression pattern of S100 calcium-binding proteins in human tumors. Int J Cancer 68: 325-332, 1996. (Pubitemid 26384135)
10. Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell 144: 646-674, 2011.
11. Hao H, Liu J, Liu G, et al: Depletion of GRIM-19 accelerates hepatocellular carcinoma invasion via inducing EMT and loss of contact inhibition. J Cell Physiol 227: 1212-1219, 2012.
12. Zhu K, Dai Z, Pan Q, et al: Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 17: 7294-7302, 2011.
13. Wang J, Chen L, Li Y and Guan XY: Overexpression of cathepsin Z contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. PLoS One 6: e24967, 2011.
14. Nagai T, Arao T, Furuta K, et al: Sorafenib inhibits the hepatocyte growth factor-mediated epithelial mesenchymal transition in hepatocellular carcinoma. Mol Cancer Ther 10: 169-177, 2011.
15. Xia L, Huang W, Tian D, et al: Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma. Hepatology 57: 610-624, 2013.
16. Strutz F, Okada H, Lo CW, et al: Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130: 393-405, 1995.
17. Cui JF, Liu YK, Zhang LJ, et al: Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro. Proteomics 6: 5953-5961, 2006.
18. Tulchinsky EM, Georgiev GP and Lukanidin EM: Novel AP-1 binding site created by DNA-methylation. Oncogene 12: 1737-1745, 1996. (Pubitemid 26146298)
19. Cohn MA, Hjelmso I, Wu LC, Guldberg P, Lukanidin EM and Tulchinsky EM: Characterization of Sp1, AP-1, CBF and KRC binding sites and minisatellite DNA as functional elements of the metastasis-associated mts1/S100A4 gene intronic enhancer. Nucleic Acids Res 29: 3335-3346, 2001. (Pubitemid 32799106)
20. Li Y, Liu ZL, Zhang KL, et al: Methylation-associated silencing of S100A4 expression in human epidermal cancers. Exp Dermatol 18: 842-848, 2009.
21. Xie R, Loose DS, Shipley GL, Xie S, Bassett RL Jr and Broaddus RR: Hypomethylation-induced expression of S100A4 in endometrial carcinoma. Mod Pathol 20: 1045-1054, 2007. (Pubitemid 47429198)
22. Rehman I, Goodarzi A, Cross SS, et al: DNA methylation and immunohistochemical analysis of the S100A4 calcium binding protein in human prostate cancer. Prostate 67: 341-347, 2007. (Pubitemid 46341075)
23. Rudland PS, Platt-Higgins A, Renshaw C, et al: Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res 60: 1595-1603, 2000. (Pubitemid 30183430)
24. Lee WY, Su WC, Lin PW, Guo HR, Chang TW and Chen HH: Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer. Oncology 66: 429-438, 2004.
25. Wang HY, Zhang JY, Cui JT, et al: Expression status of S100A14 and S100A4 correlates with metastatic potential and clinical outcome in colorectal cancer after surgery. Oncol Rep 23: 45-52, 2010.
26. Wang YY, Ye ZY, Zhao ZS, Tao HQ and Chu YQ: High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Ann Surg Oncol 17: 89-97, 2010.
27. Yonemura Y, Endou Y, Kimura K, et al: Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clin Cancer Res 6: 4234-4242, 2000.
28. Ikenaga N, Ohuchida K, Mizumoto K, et al: S100A4 mRNA is a diagnostic and prognostic marker in pancreatic carcinoma. J Gastrointest Surg 13: 1852-1858, 2009.
29. Bandiera A, Melloni G, Freschi M, et al: Prognostic factors and analysis of S100a4 protein in resected pulmonary metastases from renal cell carcinoma. World J Surg 33: 1414-1420, 2009.
30. Tarabykina S, Griffiths TR, Tulchinsky E, Mellon JK, Bronstein IB and Kriajevska M: Metastasis-associated protein S100A4: spotlight on its role in cell migration. Curr Cancer Drug Targets 7: 217-228, 2007. (Pubitemid 46699073)
31. Santamaria-Kisiel L, Rintala-Dempsey AC and Shaw GS: Calcium-dependent and -independent interactions of the S100 protein family. Biochem J 396: 201-214, 2006. (Pubitemid 43837235)
32. Ambartsumian NS, Grigorian MS, Larsen IF, et al: Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts1 gene. Oncogene 13: 1621-1630, 1996. (Pubitemid 26377493)
33. Maelandsmo GM, Hovig E, Skrede M, et al: Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme. Cancer Res 56: 5490-5498, 1996. (Pubitemid 27011385)
34. Takenaga K, Nakamura Y and Sakiyama S: Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells. Oncogene 14: 331-337, 1997. (Pubitemid 27073088)
35. Moriyama-Kita M, Endo Y, Yonemura Y, et al: S100A4 regulates E-cadherin expression in oral squamous cell carcinoma. Cancer Lett 230: 211-218, 2005. (Pubitemid 41612464)
36. Schmidt-Hansen B, Ornas D, Grigorian M, et al: Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity. Oncogene 23: 5487-5495, 2004. (Pubitemid 39044059)